At Power, we make it easy for patients to connect with leading medical research. Every day, people use withpower.com to sign up for clinical trials, and we connect them with researchers directly. We simplify recruitment with a novel AI approach, delivering qualified referrals that match protocol criteria and supporting the entire process through to enrollment, making us a favourite among research sites. For more information, go to https://www.withpower.com/

Elcam Drug Delivery Devices (E3D) is a subsidiary of Elcam Medical, an Israel-based group with 40 years of experience in the development, manufacturing, and global distribution of medical devices.E3D is focused on the design, development, manufacturing, and supply of injectable drug delivery devices for self-administration and use in non-clinical environments. Its broad technology portfolio encompasses devices suitable for drugs in a range of primary containers - including auto-injectors, on-body delivery systems, and smart devices with wireless connectivity. For more information, visit https://elcam3d.com/

Trust Bio-sonics, based in Taiwan, is a global leader in microsphere technologies for contrast-enhanced ultrasound imaging and ultrasound-mediated drug delivery. The company focuses on cardiovascular diseases and cancer, striving to offer early diagnosis and treatment solutions for patients. Trust Bio-sonics' leading diagnostic ultrasound imaging candidate, TBS-002 (a 505b1 New Drug), has commenced Phase 3 trials under the supervision of both the US FDA and Taiwan FDA. The company is also leveraging TBS-002's technology in combination with portable ultrasound to create a platform, TBS-602, for drug delivery and efficacy enhancement in pancreatic cancer treatment and other oncology applications. This platform has been shown to improve the effectiveness of conventional small-molecule chemotherapy drugs and large-molecule immunosuppressants, such as anti-PD-L1 immunotherapy. For more information, visit https://www.trust-biosonics.com/en-us/

Olfera harnesses the neuro-olfactory epithelium to develop life-changing treatments for brain diseases. Our platform enables effective delivery of therapeutic modalities to the brain and facilitates the discovery of novel drugs for neurodegenerative conditions. To learn more, please visit https://olferatx.com/

Box (NYSE:BOX) is the Intelligent Content Cloud, a single platform that enables organizations to fuel collaboration, manage the entire content lifecycle, secure critical content, and transform business workflows with enterprise AI. Founded in 2005, Box simplifies work for leading global organizations, including AstraZeneca, JLL, Morgan Stanley, and Nationwide. Box is headquartered in Redwood City, CA, with offices across the United States, Europe, and Asia. For more information, go to https://www.box.org

OCCAM Immune is a non-profit Academic Research Organization emerging from Mount Sinai Hospital that provides immune monitoring services for clinical trials. Its streamlined process, from contracting to data delivery, and its one-stop shop approach—from sample processing to assays and data analysis—bridge academic research excellence with industrial scalability. For more information, go to https://occam-immune.com/

Suntec Medical is a biotech innovator transforming cancer and CNS disease therapies with its MINC technology. MINC can deliver biologics to the brain at 100-1000x higher dosages with high efficacy and safety. Our lead drugs, STM-001 for glioma and STM-003 for Alzheimer’s, are entering Phase I/IIa trials in Q3/2024 and Q2/2025. Our portfolio includes treatments for Parkinson’s and other neural diseases. Discover more about our groundbreaking work at https://suntecmedical.com/

SonoThera is pioneering the future of genetic medicine with our groundbreaking ultrasound-guided, redosable, non-viral gene therapy platform. We offer a revolutionary approach to genetic therapies, enabling precise, non-invasive delivery of diverse genetic payloads—including large and complex formats like DNA and RNA—across virtually any organ in the body. Based in South San Francisco, SonoThera secured $60 million in Series A funding with ARCH as lead in late 2022. As we advance our pipeline of research and pre-clinical programs, we are poised to initiate our first clinical trials in 2025, setting the stage for a new era in genetic medicine. For more information, visit https://sonothera.com/

Envoya Inc. is a pioneering biotechnology company specializing in the development of non-lipid polymer-based nanoparticles for gene delivery. Leveraging cutting-edge research and innovative technology, Envoya has successfully crafted nanoparticles that stand out due to their exceptional safety and efficacy profiles. Envoya Inc. is at the forefront of a transformative wave in gene therapy, offering solutions that promise to overcome some of the most persistent challenges in the field. Their innovative use of FDA-approved, non-lipid polymers to create non-immunogenic nanoparticles with high payload encapsulation and transfection efficacy represents a significant leap forward. With a firm commitment to excellence and innovation, Envoya Inc. is poised to make a substantial impact on the future of medicine, bringing forth new possibilities for personalized and effective gene-based treatments. For more information, visit https://www.envoyabio.com/

Fzata’s vision is to be the world leader in oral biologics. We have captured the “holy grail” of oral biologics with our first-in-class live Bioengineered Probiotic Yeast Medicines (BioPYMTM) Platform. Our mission is to transform patient safety, efficacy & access to biologics with BioPYM. NIH has vetted and validated our platform; designating Fzata as an NIH Seed Company with over $27MM in grants. Fzata is also honored to be a Startup Stadium Finalist at BIO2024.

We are raising a $10M series A to support manufacturing, pipeline activities and G&A. We are also seeking pharma partners for our lead assets and/or a pilot program. For more information, please visit https://www.fzata.com/

Deep 6 AI is the leading precision research platform, enabling healthcare organizations and life sciences companies to gain visibility into study design, accelerate recruitment, and generate real-world evidence with unprecedented speed and precision. Its AI-powered software mines structured and unstructured electronic medical record data to precisely match patients to clinical trials in real time across its ecosystem of 25+ health systems. For more information, go to https://deep6.ai/

German CDMO operating in biotech and pharmaceuticals fields with core expertise in nanotechnologies & particle engineering. Our R&D labs and cGMP-manufacturing site provide end to end solutions from concept to clinical batch manufacturing including development, transfer and GMP production of nano- and microparticle formulations. We also provide Quality Control, Batch release and Stability studies. To learn more, please visit https://mybiotech.de/